Counterweight Ventures’s Nucor NUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.14M Sell
14,097
-569
-4% -$129K 1.57% 24
2026
Q1
$2.48M Buy
14,666
+1,426
+11% +$249K 1.39% 29
2025
Q4
$2.16M Sell
13,240
-36
-0.3% -$5.41K 1.21% 31
2025
Q3
$1.8M Sell
13,276
-1,705
-11% -$241K 1.05% 35
2025
Q2
$1.94M Buy
14,981
+34
+0.2% +$3.97K 1.27% 29
2025
Q1
$1.8M Buy
14,947
+482
+3% +$62.1K 1.29% 30
2024
Q4
$1.69M Buy
14,465
+344
+2% +$49.5K 1.19% 31
2024
Q3
$2.12M Buy
14,121
+2,312
+20% +$348K 1.5% 28
2024
Q2
$1.87M Buy
11,809
+404
+4% +$70.2K 1.41% 30
2024
Q1
$2.26M Buy
11,405
+275
+2% +$50.3K 1.82% 25
2023
Q4
$1.94M Buy
+11,130
New +$1.76M 1.76% 28

Other funds holding NUE

Counterweight Ventures's NUE Position: Q2 2026 in Review

Counterweight Ventures reduced its Nucor (NUE) stake by 3.9% in Q2 2026, selling an estimated $129K and leaving 14,097 shares worth $3.14M. The position accounts for 1.57% of the portfolio, ranked #24.

Counterweight Ventures first reported a position in NUE in Q4 2023 and has held it in 11 quarters since. 508 funds tracked by Wall St. Rank hold NUE as of Q2 2026.

  • Counterweight Ventures held 14,097 shares of Nucor worth $3.14M as of Q2 2026.
  • Counterweight Ventures sold 569 Nucor shares in Q2 2026, an estimated $129K.
  • Nucor made up 1.57% of Counterweight Ventures's portfolio in Q2 2026, its #24 holding.
  • Counterweight Ventures first reported a position in Nucor in Q4 2023 and has held it in 11 quarters since.
  • 508 funds tracked by Wall St. Rank held Nucor as of Q2 2026.

Based on Counterweight Ventures's 13F filing for Q2 2026, filed 23 Jul 2026.